Home » Topics » BioWorld Science

BioWorld Science
RSS

BioTheryX describes Protein Homeostatic Modulators with BTX-1188 showing notable antitumor activity

July 10, 2020

PTC Therapeutics begins first-in-human study of PTC-857 for GBA Parkinson's disease

July 10, 2020

Macrophage crosstalk inflames fat

July 10, 2020

RefleXion and Telix to study combining technologies for prostate and renal cancers

July 9, 2020

New phase II study evaluates RUC-4 in patients with STEMI

July 9, 2020

Numab begins first-in-human study of NM21-1480 for advanced solid tumors

July 9, 2020

Constant's TXA-127 to be studied for COVID-19 in phase II trials

July 9, 2020

Reverie and Roche establish multi-target collaboration

July 9, 2020

Asieris cleared in China to begin global phase III trial of Cevira for high-grade cervical dysplasia

July 9, 2020

FDA approves IND for phase I/IIa study of FCR-001 for diffuse systemic sclerosis

July 9, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...